Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

LUIS CASAUBON

Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism

NPI
1447225495
CMS profile
20091
Location
AUSTIN, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2023 · Entire year

$271.82

14 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2023 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $196.82 11
Education $75.00 3

By paying entity

PY2023 · entire year · sorted by reported total

Paying entityAmountRecords
Currax Pharmaceuticals LLC $75.00 3
Lilly USA, LLC $43.66 2
Abbott Laboratories $40.05 2
Medtronic, Inc. $38.70 2
Novo Nordisk Inc $36.09 2
Tandem Diabetes Care, Inc. $18.42 1
PFIZER INC. $13.67 1
BETA BIONICS, INC. $6.23 1

Page 1 of 1; records 1–14 of 14 matching records. This page contains 14 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

LUIS CASAUBON

NPI 1447225495 · CMS profile ID 20091

Allopathic & Osteopathic Physicians / Internal Medicine / Endocrinology, Diabetes & Metabolism

AUSTIN, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 1; records 1–14 of 14 matching records. This page contains 14 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1447225495?year=2023&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
LUIS CASAUBON, NPI 1447225495, CMS profile ID 20091. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–14 of 14 matching records. This page contains 14 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1447225495?year=2023&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
APA 7
IndustryPayments. (2026). LUIS CASAUBON, NPI 1447225495, CMS profile ID 20091. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–14 of 14 matching records. This page contains 14 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1447225495?year=2023&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
Bluebook
LUIS CASAUBON, NPI 1447225495, CMS profile ID 20091, IndustryPayments, General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 1; records 1–14 of 14 matching records. This page contains 14 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9. https://industrypayments.org/provider/npi-1447225495?year=2023&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2023 · Physicians and non-physician practitioners · CMS publication 2026-06-30

14 matching records · $271.82 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 14 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–14 of 14.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Lilly USA, LLC $26.0311/30/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1031857557 CMS
Currax Pharmaceuticals LLC $25.0011/15/2023 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 986427785 CMS
Currax Pharmaceuticals LLC $25.0011/15/2023 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 986427789 CMS
Tandem Diabetes Care, Inc. $18.4210/30/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1060265119 CMS
BETA BIONICS, INC. $6.2310/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1060384155 CMS
Currax Pharmaceuticals LLC $25.0010/18/2023 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 986427793 CMS
Novo Nordisk Inc $18.6910/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1002105111 CMS
Abbott Laboratories $15.1610/04/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1019588165 CMS
Medtronic, Inc. $21.6909/22/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1025639765 CMS
Lilly USA, LLC $17.6308/11/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1031907383 CMS
Medtronic, Inc. $17.0107/04/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1025639749 CMS
Novo Nordisk Inc $17.4004/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1002105099 CMS
Abbott Laboratories $24.8903/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1018893209 CMS
PFIZER INC. $13.6702/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1049598893 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $17.84 1
PY2021 $120.24 6
PY2022 $75.60 4
PY2023 $271.82 14
PY2024 $436.66 18
PY2025 $588.22 24

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Source files
Dataset page · Bulk file · PY2019 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $244,802.34 43
PY2024 Principal investigator $270,911.58 97
PY2023 Principal investigator $213,259.54 161
PY2022 Principal investigator $530,223.08 203
PY2021 Principal investigator $866,406.89 1,203
PY2020 Recipient $7,732.50 3
PY2020 Principal investigator $630,563.16 449
PY2019 Principal investigator $775,897.49 183

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2019

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

183 records in PY2019

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Novo Nordisk AS $46.12 12/30/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 706714841
Principal investigator 1 Novo Nordisk AS $46.12 12/27/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 706714061
Principal investigator 1 Novo Nordisk AS $3.05 12/27/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 706714889
Principal investigator 1 Novo Nordisk AS $7.40 12/27/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 706714891
Principal investigator 1 Novo Nordisk AS $46.12 12/23/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 706714101
Principal investigator 1 Novo Nordisk AS $770.62 12/19/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY PA
NN9535-4352 No dispute reported 06/30/2026 692448547
Principal investigator 1 Novo Nordisk AS $594.00 12/19/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY PA
NN9535-4352 No dispute reported 06/30/2026 692448549
Principal investigator 1 Novo Nordisk AS $2,592.00 12/19/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY PA
EX9924-4473 No dispute reported 06/30/2026 692448553
Principal investigator 1 Novo Nordisk AS $2,953.13 12/19/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY PA
NN1436-4465 No dispute reported 06/30/2026 692448563
Principal investigator 1 Novo Nordisk AS $46.12 12/10/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 706714063
Principal investigator 1 Novo Nordisk AS $540.00 12/05/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 706714107
Principal investigator 1 Novo Nordisk AS $3,259.12 12/03/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY PA
NN9535-4352 No dispute reported 06/30/2026 692448543
Principal investigator 1 Novo Nordisk AS $2,947.05 12/03/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY PA
NN9535-4352 No dispute reported 06/30/2026 692448545
Principal investigator 1 Novo Nordisk AS $5,610.38 12/03/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY PA
EX9924-4473 No dispute reported 06/30/2026 692448551
Principal investigator 1 Novo Nordisk AS $4,072.50 12/03/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY PA
NN1436-4465 No dispute reported 06/30/2026 692448559
Principal investigator 1 Novo Nordisk AS $46.12 12/02/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 706714103
Principal investigator 1 Medtronic MiniMed, Inc. $7,267.45 11/25/2019 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CEP 304 670G Outcomes Study No dispute reported 06/30/2026 660552831
Principal investigator 1 Novo Nordisk AS $45.00 11/18/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 706714743
Principal investigator 1 Abbott Laboratories $42.00 11/13/2019 Non-covered Recipient Entity
Texas Diabetes & Endocrinology
Observational Study of Effect of Insulin Administration of Glycemia in Subjects with Type 2 Diabetes No dispute reported 06/30/2026 703424215
Principal investigator 1 Abbott Laboratories $14.40 11/13/2019 Non-covered Recipient Entity
Texas Diabetes & Endocrinology
Observational Study of Effect of Insulin Administration of Glycemia in Subjects with Type 2 Diabetes No dispute reported 06/30/2026 703424217
Principal investigator 1 Abbott Laboratories $6.00 11/13/2019 Non-covered Recipient Entity
Texas Diabetes & Endocrinology
Observational Study of Effect of Insulin Administration of Glycemia in Subjects with Type 2 Diabetes No dispute reported 06/30/2026 703424219
Principal investigator 1 Abbott Laboratories $27.00 11/13/2019 Non-covered Recipient Entity
Texas Diabetes & Endocrinology
Observational Study of Effect of Insulin Administration of Glycemia in Subjects with Type 2 Diabetes No dispute reported 06/30/2026 703424221
Principal investigator 1 Abbott Laboratories $18.99 11/13/2019 Non-covered Recipient Entity
Texas Diabetes & Endocrinology
Observational Study of Effect of Insulin Administration of Glycemia in Subjects with Type 2 Diabetes No dispute reported 06/30/2026 703424223
Principal investigator 1 Medtronic MiniMed, Inc. $274.00 11/13/2019 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CEP 304 670G Outcomes Study No dispute reported 06/30/2026 660552825
Principal investigator 1 Medtronic MiniMed, Inc. $12,772.45 11/06/2019 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CEP 304 670G Outcomes Study No dispute reported 06/30/2026 660552821
Principal investigator 1 Novo Nordisk AS $4,694.64 10/31/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY PA
NN9535-4352 No dispute reported 06/30/2026 692448471
Principal investigator 1 Novo Nordisk AS $1,782.00 10/31/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY PA
NN9535-4352 No dispute reported 06/30/2026 692448473
Principal investigator 1 Novo Nordisk AS $92.00 10/31/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY PA
NN9535-4352 No dispute reported 06/30/2026 692448475
Principal investigator 1 Novo Nordisk AS $63.00 10/29/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY PA
EX9924-4473 No dispute reported 06/30/2026 692448477
Principal investigator 1 Novo Nordisk AS $4,366.69 10/29/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY PA
EX9924-4473 No dispute reported 06/30/2026 692448479
Principal investigator 1 Novo Nordisk AS $5,000.00 10/29/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY PA
NN1436-4465 No dispute reported 06/30/2026 692448483
Principal investigator 1 Novo Nordisk AS $10,932.97 10/29/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY PA
NN1436-4465 No dispute reported 06/30/2026 692448485
Principal investigator 1 Novo Nordisk AS $45.00 10/11/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 706714679
Principal investigator 1 Novo Nordisk AS $450.00 10/11/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 706714681
Principal investigator 1 Novo Nordisk AS $126.00 09/26/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY PA
NN9535-4352 No dispute reported 06/30/2026 692448505
Principal investigator 1 Novo Nordisk AS $4,169.84 09/26/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY PA
NN9535-4352 No dispute reported 06/30/2026 692448507
Principal investigator 1 Novo Nordisk AS $4,217.07 09/26/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY PA
EX9924-4473 No dispute reported 06/30/2026 692448515
Principal investigator 1 Novo Nordisk AS $7,554.60 09/26/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY PA
NN1436-4465 No dispute reported 06/30/2026 692448541
Principal investigator 1 Medtronic MiniMed, Inc. $9,148.70 09/18/2019 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CEP 304 670G Outcomes Study No dispute reported 06/30/2026 660552817
Principal investigator 1 Novo Nordisk AS $80.20 09/12/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 706714623
Principal investigator 1 Novo Nordisk AS $45.00 09/12/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 706714625
Principal investigator 1 Novo Nordisk AS $360.00 09/12/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 706714627
Principal investigator 1 Novo Nordisk AS $5.30 09/12/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 706714629
Principal investigator 1 Novo Nordisk AS $1.12 09/12/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 706714631
Principal investigator 1 Novo Nordisk AS $9.80 09/12/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 706714633
Principal investigator 1 Novo Nordisk AS $60.00 09/12/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 706714635
Principal investigator 1 Novo Nordisk AS $6.50 09/12/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 706714637
Principal investigator 1 Novo Nordisk AS $9.80 09/12/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 706714639
Principal investigator 1 Novo Nordisk AS $36.00 09/12/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 706714641
Principal investigator 1 Novo Nordisk AS $1,167.00 09/10/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4465 No dispute reported 06/30/2026 706713995
Principal investigator 1 Novo Nordisk AS $9,480.38 08/30/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY PA
NN9535-4352 No dispute reported 06/30/2026 692448501
Principal investigator 1 Novo Nordisk AS $4,660.20 08/30/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY PA
NN9535-4352 No dispute reported 06/30/2026 692448503
Principal investigator 1 Novo Nordisk AS $4,564.70 08/30/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY PA
EX9924-4473 No dispute reported 06/30/2026 692448513
Principal investigator 1 Novo Nordisk AS $4,628.47 08/30/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY PA
NN1436-4465 No dispute reported 06/30/2026 692448537
Principal investigator 1 Novo Nordisk AS $7.95 08/14/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 706714563
Principal investigator 1 Novo Nordisk AS $1.68 08/14/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 706714565
Principal investigator 1 Novo Nordisk AS $14.70 08/14/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 706714567
Principal investigator 1 Novo Nordisk AS $90.00 08/14/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 706714569
Principal investigator 1 Novo Nordisk AS $9.75 08/14/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 706714571
Principal investigator 1 Novo Nordisk AS $14.70 08/14/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 706714573
Principal investigator 1 Novo Nordisk AS $54.00 08/14/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 706714575
Principal investigator 1 Medtronic MiniMed, Inc. $7,414.55 08/13/2019 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CEP 304 670G Outcomes Study No dispute reported 06/30/2026 660552811
Principal investigator 1 Novo Nordisk AS $5.10 08/13/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 706714577
Principal investigator 1 Novo Nordisk AS $49.98 08/13/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 706714579
Principal investigator 1 Novo Nordisk AS $9.00 08/13/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 706714581
Principal investigator 1 Novo Nordisk AS $60.00 08/13/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 706714583
Principal investigator 1 Novo Nordisk AS $6.50 08/13/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 706714585
Principal investigator 1 Novo Nordisk AS $9.80 08/13/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 706714587
Principal investigator 1 Novo Nordisk AS $36.00 08/13/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 706714589
Principal investigator 1 Novo Nordisk AS $12.75 08/06/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 706714541
Principal investigator 1 Novo Nordisk AS $124.95 08/06/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 706714543
Principal investigator 1 Novo Nordisk AS $22.50 08/06/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 706714545
Principal investigator 1 Novo Nordisk AS $150.00 08/06/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 706714547
Principal investigator 1 Novo Nordisk AS $16.25 08/06/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 706714549
Principal investigator 1 Novo Nordisk AS $24.50 08/06/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 706714551
Principal investigator 1 Novo Nordisk AS $90.00 08/06/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 706714553
Principal investigator 1 Medtronic MiniMed, Inc. $15,634.75 07/30/2019 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CEP 304 670G Outcomes Study No dispute reported 06/30/2026 660552807
Principal investigator 1 Novo Nordisk AS $1,000.00 07/30/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY PA
NN1218-4113 No dispute reported 06/30/2026 692448415
Principal investigator 1 Novo Nordisk AS $6,812.44 07/30/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY PA
NN9535-4352 No dispute reported 06/30/2026 692448497
Principal investigator 1 Novo Nordisk AS $3,495.15 07/30/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY PA
NN9535-4352 No dispute reported 06/30/2026 692448499
Principal investigator 1 Novo Nordisk AS $2,500.00 07/30/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY PA
EX9924-4473 No dispute reported 06/30/2026 692448509
Principal investigator 1 Novo Nordisk AS $1,000.00 07/30/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY PA
EX9924-4473 No dispute reported 06/30/2026 692448511
Principal investigator 1 Novo Nordisk AS $3,000.00 07/30/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY PA
NN1436-4465 No dispute reported 06/30/2026 692448529
Principal investigator 1 Novo Nordisk AS $9,375.75 07/30/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY PA
NN1436-4465 No dispute reported 06/30/2026 692448533
Principal investigator 1 Novo Nordisk AS $180.00 07/16/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 706714487
Principal investigator 1 Novo Nordisk AS $80.20 07/12/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 706714477
Principal investigator 1 Novo Nordisk AS $45.00 07/12/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 706714479
Principal investigator 1 Novo Nordisk AS $69.18 07/09/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 706714467
Principal investigator 1 Novo Nordisk AS $1,745.00 07/03/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4465 No dispute reported 06/30/2026 706714009
Principal investigator 1 Medtronic MiniMed, Inc. $328.71 07/02/2019 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CEP 304 670G Outcomes Study No dispute reported 06/30/2026 660552799
Principal investigator 1 Medtronic MiniMed, Inc. $30.00 07/02/2019 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CEP 304 670G Outcomes Study No dispute reported 06/30/2026 660552803
Principal investigator 1 Novo Nordisk AS $2,000.00 07/02/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY PA
NN9535-4352 No dispute reported 06/30/2026 692448527
Principal investigator 1 Novo Nordisk AS $79.96 07/02/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 706714461
Principal investigator 1 Novo Nordisk AS $69.18 07/02/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 706714463
Principal investigator 1 Novo Nordisk AS $69.18 06/27/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 706714459
Principal investigator 1 Novo Nordisk AS $69.18 06/26/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 706714455
Principal investigator 1 Novo Nordisk AS $69.18 06/26/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 706714457
Principal investigator 1 Novo Nordisk AS $10,941.36 06/25/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY PA
NN1218-4113 No dispute reported 06/30/2026 692448409
Principal investigator 1 Novo Nordisk AS $2,000.00 06/25/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY PA
NN9535-4352 No dispute reported 06/30/2026 692448447
Principal investigator 1 Medtronic MiniMed, Inc. $15,545.75 06/23/2019 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CEP 304 670G Outcomes Study No dispute reported 06/30/2026 660552795
Principal investigator 1 Novo Nordisk AS $69.18 06/14/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 706714445
Principal investigator 1 Novo Nordisk AS $10.60 06/13/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 706714409
Principal investigator 1 Novo Nordisk AS $2.24 06/13/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 706714411
Principal investigator 1 Novo Nordisk AS $19.60 06/13/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 706714413
Principal investigator 1 Novo Nordisk AS $120.00 06/13/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 706714415
Principal investigator 1 Novo Nordisk AS $13.00 06/13/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 706714417
Principal investigator 1 Novo Nordisk AS $19.60 06/13/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 706714419
Principal investigator 1 Novo Nordisk AS $72.00 06/13/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 706714421
Principal investigator 1 Novo Nordisk AS $2.65 06/10/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 706714381
Principal investigator 1 Novo Nordisk AS $0.56 06/10/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 706714383
Principal investigator 1 Novo Nordisk AS $4.90 06/10/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 706714385
Principal investigator 1 Novo Nordisk AS $30.00 06/10/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 706714387
Principal investigator 1 Novo Nordisk AS $3.25 06/10/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 706714389
Principal investigator 1 Novo Nordisk AS $4.90 06/10/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 706714391
Principal investigator 1 Novo Nordisk AS $18.00 06/10/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 706714393
Principal investigator 1 Novo Nordisk AS $69.18 06/07/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 706714365
Principal investigator 1 Novo Nordisk AS $5.10 06/05/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4465 No dispute reported 06/30/2026 706714349
Principal investigator 1 Novo Nordisk AS $1.12 06/05/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4465 No dispute reported 06/30/2026 706714351
Principal investigator 1 Novo Nordisk AS $9.00 06/05/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4465 No dispute reported 06/30/2026 706714353
Principal investigator 1 Novo Nordisk AS $60.00 06/05/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4465 No dispute reported 06/30/2026 706714355
Principal investigator 1 Novo Nordisk AS $8.70 06/05/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4465 No dispute reported 06/30/2026 706714357
Principal investigator 1 Novo Nordisk AS $9.80 06/05/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4465 No dispute reported 06/30/2026 706714359
Principal investigator 1 Novo Nordisk AS $36.00 06/05/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4465 No dispute reported 06/30/2026 706714361
Principal investigator 1 Novo Nordisk AS $2.55 05/31/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4465 No dispute reported 06/30/2026 706714333
Principal investigator 1 Novo Nordisk AS $4.50 05/31/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4465 No dispute reported 06/30/2026 706714335
Principal investigator 1 Novo Nordisk AS $4.90 05/31/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4465 No dispute reported 06/30/2026 706714337
Principal investigator 1 Novo Nordisk AS $5.69 05/31/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4465 No dispute reported 06/30/2026 706714339
Principal investigator 1 Novo Nordisk AS $4.90 05/31/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4465 No dispute reported 06/30/2026 706714341
Principal investigator 1 Novo Nordisk AS $1.50 05/31/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4465 No dispute reported 06/30/2026 706714343
Principal investigator 1 Novo Nordisk AS $1.50 05/31/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4465 No dispute reported 06/30/2026 706714345
Principal investigator 1 Novo Nordisk AS $18.00 05/31/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4465 No dispute reported 06/30/2026 706714347
Principal investigator 1 Novo Nordisk AS $117.78 05/28/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 706714305
Principal investigator 1 Medtronic MiniMed, Inc. $18,811.40 05/23/2019 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CEP 304 670G Outcomes Study No dispute reported 06/30/2026 660552791
Principal investigator 1 Novo Nordisk AS $12.99 05/22/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4465 No dispute reported 06/30/2026 706714283
Principal investigator 1 Novo Nordisk AS $5.69 05/22/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4465 No dispute reported 06/30/2026 706714285
Principal investigator 1 Novo Nordisk AS $2.55 05/22/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4465 No dispute reported 06/30/2026 706714287
Principal investigator 1 Novo Nordisk AS $0.56 05/22/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4465 No dispute reported 06/30/2026 706714289
Principal investigator 1 Novo Nordisk AS $4.50 05/22/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4465 No dispute reported 06/30/2026 706714291
Principal investigator 1 Novo Nordisk AS $30.00 05/22/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4465 No dispute reported 06/30/2026 706714293
Principal investigator 1 Novo Nordisk AS $4.35 05/22/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4465 No dispute reported 06/30/2026 706714295
Principal investigator 1 Novo Nordisk AS $4.90 05/22/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4465 No dispute reported 06/30/2026 706714297
Principal investigator 1 Novo Nordisk AS $18.00 05/22/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4465 No dispute reported 06/30/2026 706714299
Principal investigator 1 Novo Nordisk AS $607.00 05/22/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
EX9924-4473 No dispute reported 06/30/2026 706714873
Principal investigator 1 Novo Nordisk AS $18.00 05/15/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4465 No dispute reported 06/30/2026 706714273
Principal investigator 1 Novo Nordisk AS $698.00 05/14/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4465 No dispute reported 06/30/2026 706713933
Principal investigator 1 Medtronic MiniMed, Inc. $442.99 05/09/2019 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CEP 304 670G Outcomes Study No dispute reported 06/30/2026 660552787
Principal investigator 1 Novo Nordisk AS $1,396.00 05/06/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4465 No dispute reported 06/30/2026 706713935
Principal investigator 1 Novo Nordisk AS $114.61 05/03/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 706713967
Principal investigator 1 Novo Nordisk AS $2.55 05/03/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4465 No dispute reported 06/30/2026 706714227
Principal investigator 1 Novo Nordisk AS $5.69 05/03/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4465 No dispute reported 06/30/2026 706714229
Principal investigator 1 Novo Nordisk AS $4.35 05/03/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4465 No dispute reported 06/30/2026 706714231
Principal investigator 1 Novo Nordisk AS $4.90 05/03/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4465 No dispute reported 06/30/2026 706714233
Principal investigator 1 Novo Nordisk AS $1.50 05/03/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4465 No dispute reported 06/30/2026 706714235
Principal investigator 1 Novo Nordisk AS $1.50 05/03/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4465 No dispute reported 06/30/2026 706714237
Principal investigator 1 Novo Nordisk AS $12.99 05/03/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4465 No dispute reported 06/30/2026 706714239
Principal investigator 1 Novo Nordisk AS $5.69 05/03/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4465 No dispute reported 06/30/2026 706714241
Principal investigator 1 Novo Nordisk AS $5.10 05/03/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4465 No dispute reported 06/30/2026 706714243
Principal investigator 1 Novo Nordisk AS $1.12 05/03/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4465 No dispute reported 06/30/2026 706714245
Principal investigator 1 Novo Nordisk AS $9.00 05/03/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4465 No dispute reported 06/30/2026 706714247
Principal investigator 1 Novo Nordisk AS $60.00 05/03/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4465 No dispute reported 06/30/2026 706714249
Principal investigator 1 Novo Nordisk AS $8.70 05/03/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4465 No dispute reported 06/30/2026 706714251
Principal investigator 1 Novo Nordisk AS $9.80 05/03/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4465 No dispute reported 06/30/2026 706714253
Principal investigator 1 Novo Nordisk AS $36.00 05/03/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4465 No dispute reported 06/30/2026 706714255
Principal investigator 1 Novo Nordisk AS $114.61 05/02/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 706713969
Principal investigator 1 Novo Nordisk AS $3.05 04/30/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 706714203
Principal investigator 1 Novo Nordisk AS $1.08 04/30/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 706714205
Principal investigator 1 Novo Nordisk AS $22.76 04/30/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 706714207
Principal investigator 1 Novo Nordisk AS $117.78 04/30/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 706714209
Principal investigator 1 Novo Nordisk AS $4.80 04/30/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 706714211
Principal investigator 1 Novo Nordisk AS $5.10 04/30/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 706714213
Principal investigator 1 Novo Nordisk AS $49.98 04/30/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 706714215
Principal investigator 1 Novo Nordisk AS $9.00 04/30/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 706714217
Principal investigator 1 Novo Nordisk AS $60.00 04/30/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 706714219
Principal investigator 1 Novo Nordisk AS $6.50 04/30/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 706714221
Principal investigator 1 Novo Nordisk AS $9.80 04/30/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 706714223
Principal investigator 1 Novo Nordisk AS $36.00 04/30/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4352 No dispute reported 06/30/2026 706714225
Principal investigator 1 Medtronic MiniMed, Inc. $40,481.40 04/23/2019 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CEP 304 670G Outcomes Study No dispute reported 06/30/2026 660552783
Principal investigator 1 Medtronic MiniMed, Inc. $19,429.80 03/21/2019 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CEP 304 670G Outcomes Study No dispute reported 06/30/2026 660552779
Principal investigator 1 Novo Nordisk AS $500.00 03/05/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY PA
NN1218-4113 No dispute reported 06/30/2026 692448403
Principal investigator 1 Novo Nordisk AS $10,000.00 02/26/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY PA
NN9924-4221 No dispute reported 06/30/2026 692448427
Principal investigator 1 Novo Nordisk AS $1,000.00 02/21/2019 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY PA
NN9924-4221 No dispute reported 06/30/2026 692448425
Principal investigator 1 Medtronic MiniMed, Inc. $453,835.30 01/23/2019 Non-covered Recipient Entity
Texas Diabetes And Endocrinology P.A.
CEP 304 670G Outcomes Study No dispute reported 06/30/2026 660554643
Principal investigator 1 Medtronic MiniMed, Inc. $20,950.65 01/22/2019 Non-covered Recipient Entity
Texas Diabetes & Endocrinology Pa
CEP 304 670G Outcomes Study No dispute reported 06/30/2026 660552773